Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yichang Sanxia Pharmaceutical, historically known as the Yichang Veterinary Medicine Factory, is a prominent Chinese pharmaceutical manufacturer specializing in antibiotics and active pharmaceutical ingredients (APIs). The company is a leading global producer of Neomycin Sulfate and Oxytetracycline, catering to both human and veterinary medicine sectors. As a subsidiary of Humanwell Healthcare Group, it operates extensive GMP-compliant fermentation and synthesis facilities in Yichang, Hubei. Its product portfolio also includes amino acids like L-isoleucine and various finished dosage forms for the domestic and international markets. The company maintains a strong focus on export, with products registered and sold in numerous countries worldwide. It plays a critical role in the global supply chain for animal health products and essential antibiotics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yichang Veterinary Medicine Factory.